Mediracer’s goal: big in Japan, then the world

MediracerMEDIRACERThe Mediracer NCS system can detect the presence of carpal canal syndrome. It has now been certified for the Japanese markets.

Mediracer, a company from Oulu, northern Finland, has gained access to the Japanese health care markets and is now going for global growth.

Mediracer has developed a system for detecting carpal tunnel syndrome (CTS) at local health care units, without the need to consult a specialist. According to Mediracer, the system speeds up the treatment process and brings in savings thanks to instant diagnosis, which also cuts down on time spend in queues and on sick leave. Generally 2 to 4 per cent of the population suffer from CTS and 10 per cent from numbness of the hands.

The final certificate for the Japanese markets was received last year. According to Mediracer, the approval process is lengthy in Japan: registration of a medical device must be preceded by local registration of the manufacturer.

The Mediracer NCS system now has a refunding code thanks to which Japanese patients can receive a 70% refund on the medical costs. The code is practically the key that opens the door to the Japanese health care markets.  Around 50 health care units in Finland use Mediracer NCS devices. 
Good News from Finland